Eurobio Scientific (STU:E8TN) ROCE %: 4.58% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:E8TN Eurobio Scientific STU:E8TN
69 GF Score
Price €20.40
GF Value €25.22
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eurobio Scientific ROCE %?

Eurobio Scientific STU:E8TN +0.49% 69 ROCE % is 4.58% as of Dec. 2025. GuruFocus rates STU:E8TN with a GF Score™ of 69/100 and a GF Value™ of €25.22 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Eurobio Scientific's annualized ROCE % for the quarter that ended in Dec. 2025 was 4.58%.

Eurobio Scientific  (STU:E8TN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Eurobio Scientific ROCE % Related Terms

Eurobio Scientific ROCE % Historical Data

* Premium members only.

The historical data trend for Eurobio Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurobio Scientific ROCE % Chart

Eurobio Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.13 13.84 4.22 4.34 4.57

Eurobio Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.64 6.15 1.99 4.50 4.58
STU:E8TN
69GF Score
Eurobio Scientific STU:E8TN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurobio Scientific ROCE % Calculation

Eurobio Scientific's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=9.743/( ( (257.168 - 41.351) + (256.756 - 46.245) )/ 2 )
=9.743/( (215.817+210.511)/ 2 )
=9.743/213.164
=4.57 %

Eurobio Scientific's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=9.77/( ( (259.938 - 43.728) + (256.756 - 46.245) )/ 2 )
=9.77/( ( 216.21 + 210.511 )/ 2 )
=9.77/213.3605
=4.58 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.58% mean?
Eurobio Scientific (STU:E8TN) has a ROCE % of 4.58% as of Dec. 2025.
Is Eurobio Scientific's ROCE % too high?
Eurobio Scientific's current ROCE % is 4.58%. The Medical Devices & Instruments industry median ROCE % is 2.18. Eurobio Scientific's value of 4.58% is 110.1% above this industry median. Overall, Eurobio Scientific has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurobio Scientific's ROCE % compare to ABT and SYK?
Eurobio Scientific's ROCE % of 4.58% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.18. Eurobio Scientific's value of 4.58% is 110.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.18, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurobio Scientific's current ROCE % of 4.58% is 110.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurobio Scientific's current ROCE % is 4.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurobio Scientific stock overvalued right now?
Based on GuruFocus' analysis, Eurobio Scientific (STU:E8TN) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.22, compared to a current price of €20.40 — trading 19.1% below its estimated fair value. The current ROCE % is 4.58% and 110.1% above the Medical Devices & Instruments industry median of 2.18. Eurobio Scientific's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Eurobio Scientific (STU:E8TN), the current ROCE % is 4.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurobio Scientific (STU:E8TN) Overvalued in 2026?

Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued. The current stock price of €20.40 is trading 19.1% below its estimated GF Value™ of €25.22. GuruFocus considers Eurobio Scientific to be Modestly Undervalued.

Key valuation signals for STU:E8TN:

  • ROCE %: 4.58%
  • GF Value™: €25.22 vs. price of €20.40 (19.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs
  • Industry Position: 110.1% above the Medical Devices & Instruments median

No single metric tells the full story. See the STU:E8TN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurobio Scientific Business Description

Other Exchanges ALERS:France
Address 63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
69GF Score

Get the complete analysis for STU:E8TN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.40
Price
€25.22
GF Value